NGM Biopharmaceuticals Inc (NASDAQ:NGM)
| 13.78 Delayed Data As of May 27 |  +0.39 / +2.91%Today’s Change | 10.49 Today|||52-Week Range 27.25 | -22.19% Year-to-Date |
Latest NGM News | Press Releases
No recent news for NGM Biopharmaceuticals Inc.
Today’s Trading
| Previous close | 13.39 |
| Today’s open | 13.74 |
| Day’s range | 13.40 - 13.84 |
| Volume | 6,176 |
| Average volume (3 months) | 294,333 |
| Market cap | $1.1B |
Data as of 4:00pm ET, 05/27/2022
Growth & Valuation
| Earnings growth (last year) | -4.30% |
| Earnings growth (this year) | -32.31% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -10.86% |
| P/E ratio | NM |
| Price/Sales | 17.53 |
| Price/Book | 3.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IOVAIovance Biotherapeut... | -8.11 | -53.60% |
| SAVACassava Sciences Inc | +1.17 | +4.59% |
| ALLOAllogene Therapeutic... | +0.50 | +6.67% |
| MYOVMyovant Sciences Ltd | +0.83 | +8.28% |
Data as of 5:11pm ET, 05/27/2022
Financials
| Next reporting date | August 16, 2022 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $77.9M |
| Annual profit (last year) | -$120.3M |
| Net profit margin | -154.51% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
